Surgery Partners, Inc. (SGRY) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
SGRY EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SGRY Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 23.1% | 11.8% | -2.4% |
| 2024 | 23.9% | 11.2% | -5.4% |
| 2023 | 23.6% | 12.0% | -0.4% |
| 2022 | 22.6% | 13.6% | -2.2% |
| 2021 | 22.1% | 13.6% | -3.2% |
Download Data
Export SGRY earnings history in CSV or JSON format
Free sign-in required to download data
Surgery Partners, Inc. (SGRY) Earnings Overview
As of May 8, 2026, Surgery Partners, Inc. (SGRY) reported trailing twelve-month net income of -$76M, reflecting +54.1% year-over-year growth. The company earned $-0.59 per diluted share over the past four quarters, with a net profit margin of -2.4%.
Looking at the long-term picture, SGRY's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2016.
Surgery Partners, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including USPH ($11M net income, 1.9% margin), SEM ($134M net income, 2.7% margin), AMSF ($46M net income, 14.9% margin), SGRY has room to improve margins relative to the peer group. Compare SGRY vs USPH →
SGRY Earnings vs Peers
Earnings metrics vs comparable public companies
SGRY Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$78M | +53.7% | $390M | $-0.61 | -2.4% | 11.8% |
| 2024 | -$168M | -1312.6% | $349M | $-1.33 | -5.4% | 11.2% |
| 2023 | -$12M | +78.2% | $328M | $-0.09 | -0.4% | 12.0% |
| 2022 | -$55M | +23.0% | $345M | $-0.59 | -2.2% | 13.6% |
| 2021 | -$71M | +38.9% | $302M | $-1.12 | -3.2% | 13.6% |
| 2020 | -$116M | -55.2% | $183M | $-3.19 | -6.2% | 9.8% |
| 2019 | -$75M | +63.6% | $236M | $0.95 | -4.1% | 12.9% |
| 2018 | -$206M | -288.2% | $78M | $-4.28 | -11.6% | 4.4% |
| 2017 | -$53M | -660.5% | $158M | $-1.08 | -4.0% | 11.8% |
| 2016 | $9M | +561.5% | $196M | $0.20 | 0.8% | 17.2% |
See SGRY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SGRY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SGRY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSGRY — Frequently Asked Questions
Quick answers to the most common questions about buying SGRY stock.
Is SGRY growing earnings?
SGRY EPS is $-0.59, with earnings growth accelerating to +54.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-76M.
What are SGRY's profit margins?
Surgery Partners, Inc. net margin is -2.4%, with operating margin at +11.8%. Below-average margins reflect competitive or cost pressures.
How consistent are SGRY's earnings?
SGRY earnings data spans 2013-2025. The accelerating earnings trend is +54.1% YoY. Historical data enables comparison across business cycles.